Prestige Consumer Healthcare
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Prestige Consumer Healthcare generated cash of $248,926,000, which is more than the previous year. Cash used in financing activities reached the amount of -$241,015,000 last year. Net change in cash is therefore -$12,020,000.
Cash Flow
| 2015 | 156.25M | -805.25M | 643.26M |
|---|---|---|---|
| 2016 | 174.35M | -222.97M | 54.03M |
| 2017 | 147.77M | -694.59M | 561.85M |
| 2018 | 210.11M | -11.56M | -208.95M |
| 2019 | 189.28M | 55.43M | -249.32M |
| 2020 | 217.12M | -16.57M | -131.43M |
| 2021 | 235.60M | -22.24M | -279.41M |
| 2022 | 259.92M | -256.51M | -7.56M |
| 2023 | 229.71M | -11.58M | -185.84M |
| 2024 | 248.92M | -20.11M | -241.01M |
PBH Cash Flow Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 58.48M | 27.18M | 32.30M | 94.76M | 27.53M | 32.54M | 41.85M | 27.23M | 21.31M | 28.33M |
Operating activities | ||||||||||
Net income | 209.33M | -82.30M | 205.38M | 164.68M | 142.28M | -35.8M | 339.57M | 69.39M | 99.90M | 78.26M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 30.67M | 32.62M | 32.09M | 30.16M | 28.99M | 31.77M | 33.42M | 25.79M | 23.67M | 17.74M |
Stock-based compensation expense | 14.01M | 12.40M | 9.03M | 8.54M | 7.64M | 7.43M | 8.90M | 8.14M | 9.95M | 6.91M |
| Deferred income tax benefit | 14.01M | 12.40M | 9.03M | 8.54M | 7.64M | 7.43M | 8.90M | 8.14M | 9.95M | 6.91M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -6.32M | -24.92M | -24.65M | 36.87M | -2.84M | -2.98M | -5.04M | -18.93M | 1.82M | 1.60M |
Inventories | 24.43M | -42.22M | 663K | 2.97M | 2.93M | -10.53M | -2.48M | -10.26M | -3.00M | 15.36M |
Accounts payable | -24.97M | 7.25M | 9.15M | -17.34M | 6.21M | -3.99M | -10.02M | 21.44M | -11.34M | -17.63M |
Cash generated by operating activities | 248.92M | 229.71M | 259.92M | 235.60M | 217.12M | 189.28M | 210.11M | 147.77M | 174.35M | 156.25M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -9.55M | -7.78M | -9.64M | -22.24M | -17.32M | -10.48M | -12.53M | -2.97M | -3.56M | -6.10M |
Acquisitions Net | -10.56M | -3.8M | -247.04M | 0 | -2.76M | 65.91M | 0 | -693.12M | -226.98M | -809.15M |
Cash generated by investing activities | -20.11M | -11.58M | -256.51M | -22.24M | -16.57M | 55.43M | -11.56M | -694.59M | -222.97M | -805.25M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 7.04M | 2.85M | 1.32M | 0 | 1.62M | 4.02M | 7.23M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -25M | -50M | -2.91M | -11.86M | -56.72M | -49.97M | -1.07M | -1.43M | -2.22M | -2.10M |
Repayments of term debt | -227.82M | -137.75M | -11.69M | -866.44M | -568.47M | -200M | -489M | 569.5M | -486.1M | 656.1M |
Cash used in financing activities | -241.01M | -185.84M | -7.56M | -279.41M | -131.43M | -249.32M | -208.95M | 561.85M | 54.03M | 643.26M |
Net Change In Cash | -12.02M | 31.30M | -5.11M | -62.45M | 67.23M | -5.01M | -9.30M | 14.62M | 5.91M | -7.01M |
Cash at end of period | 46.46M | 58.48M | 27.18M | 32.30M | 94.76M | 27.53M | 32.54M | 41.85M | 27.23M | 21.31M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |